AQC-Pattern Accordion-Collapse Accordion-Expand Agenda-Map CROs Consulting Download Email Fax Filter-Check Filter-Remove LinkedIn Map-Pin Member-Login Pharma-Biotech-Devices Phone Summit-Registration Survey-Research The-Avoca-Group-Consulting-And-Research-Services-Horizontal The-Avoca-Group-Diligent-Prequalification-Platform-Horizontal The-Avoca-Group-Quality-Consortium-Horizontal Training avoca-logo-coloravoca-logo-graycheckconsulting_logo2 diligent_logo2 dots dotted-01 dotted down-arrow GroupCreated with Sketch. minus plus quality_logo2 right-arrow twitter

2019 Avoca Industry Report: Quality Oversight


Each year, The Avoca Group surveys industry professionals to understand trends in clinical development, with a particular focus on outsourcing dynamics and relationships between research Sponsors and Providers. This report summarizes key findings with respect to outsourcing trends and key relationship indicators, including analysis of the influence of specific performance attributes on levels of satisfaction.

In this year’s industry review, Avoca examined how Sponsors and Providers think about and manage quality in clinical trials. This topic is a continuation of research first conducted in 2011, and longitudinal comparisons of key variables are noted, where applicable.


Access Report ››


Key Implications

  • Persistent, widening gaps in perceptions of quality between Sponsors and Providers are heavily influenced by the ‘softer’ elements of quality oversight – effective, open communication regarding expectations, risk, and issues.
  • More progressive, proactive quality management tools and practices are less frequently used and perceived to be less effective despite encouraged use in recent regulatory guidance.


Click here to access The 2019 Avoca State of the Industry Report: Quality Oversight in Clinical Outsourcing, as well as Avoca’s past research reports.